Saniona
6.89
SEK
+0.44 %
Less than 1K followers
SANION
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
+0.44%
-25.27%
-14.3%
+6%
+42.21%
+232.85%
+56.6%
-58.79%
+75.93%
Saniona is a biotechnology company focused on developing innovative treatments for neurological and psychiatric diseases. The company is researching new therapies that can improve patient outcomes and quality of life. The company operates globally with a primary presence in Europe and North America. Saniona was founded in 2011 and is headquartered in Stockholm, Sweden.
Read moreMarket cap
775.35M SEK
Turnover
1.55M SEK
Revenue
334.67M
EBIT %
72.28 %
P/E
3.89
Dividend yield-%
-
Financial calendar
28.5
2025
General meeting '25
28.5
2025
Interim report Q1'25
28.8
2025
Interim report Q2'25
ShowingAll content types
Saniona and Boehringer Ingelheim extend research collaboration with one year
Saniona Appoints Pierandrea Muglia, M.D., as Chief Medical Officer
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools